"I always wonder with SA articles if they are written by the people buying to try to cause a quick boost, or if they write the articles, and then wait to release them after a quick jump so it looks like they know what they are talking about..."
Are you kidding? You seem like a very intelligent guy and you don't know the answer to this?
dscobash, your latest diatribe is preposterous. How would you like to take on a very difficult situation and be judged so harshly only after a few weeks? Give the guy a few quarters to start turning things around. Meanwhile, give it a rest and stop shooting off your vile mouth. Perhaps your short desk handlers should reassign you for a while.
decapod401, pay no attention to keerxaeezs. No doubt he's the type who gets off mugging little old ladies and torturing small animals. With that said, I can't possibly believe that any mature individual would engage in such behavior so more than likely he's nothing more than a mentally handicapped troll.
Don't get too excited. These studies were conducted in vitro and in mouse xenograft models...still years away before proven to work in humans. Nevertheless, it's good news because Z supports the principle of tumor targeting as already employed by AEZS-108.
Geez, dscobash, you sure can dish it out but you certainly can't take it. You write like a frustrated underpaid attorney working part time for a trading desk with a huge short interest in AEZS. Am I close?
In any event, the truth is that without a doubt you have been right most of the time. The problem is that you have been overly heavy handed. No need to kill a fly with a nuclear missile. Everyone here knows the company sux and is a long shot to recover.
Proxy votes are a waste of time. The game is rigged, especially with small caps. Retail investors almost never collectively have enough votes to affect change.